Phase 1 Study and Dose Seeking Study of an Intravenous Formulation of the Anthracycline Analog GPX-150 in Patients With Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 14 Nov 2017
At a glance
- Drugs GPX 150 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; First in man
- Sponsors Gem Pharmaceuticals
- 14 Nov 2017 Results published in the Monopar Therapeuticsthe Media Release.
- 12 Feb 2015 Results published in the Investigational New Drugs.
- 04 Aug 2014 Status changed from suspended to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History